PubMed

Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes.

Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL.

Diabetes Care. 2005 Jan;28(1):10-4.PMID: 15616226 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin.

Kudva YC, Basu A, Jenkins GD, Pons GM, Vogelsang DA, Rizza RA, Smith SA, Isley WL.

Endocr Pract. 2007 May-Jun;13(3):244-50.PMID: 17599855 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program.

Philis-Tsimikas A, Zhang Q, Walker C.

Am J Ther. 2006 Nov-Dec;13(6):466-72.PMID: 17122525 [PubMed - indexed for MEDLINE]Related articles

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.

White NH, Chase HP, Arslanian S, Tamborlane WV; 4030 Study Group.

Diabetes Care. 2009 Mar;32(3):387-93. Epub 2008 Dec 23.PMID: 19106380 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB.

Diabetes. 2000 Dec;49(12):2142-8.PMID: 11118018 [PubMed - indexed for MEDLINE]Related articlesFree article

Dosing of insulin glargine in the treatment of type 2 diabetes.

Barnett A.

Clin Ther. 2007 Jun;29(6):987-99. Review.PMID: 17692716 [PubMed - indexed for MEDLINE]Related articles

Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.

Alemzadeh R, Berhe T, Wyatt DT.

Pediatrics. 2005 May;115(5):1320-4.PMID: 15867042 [PubMed - indexed for MEDLINE]Related articlesFree article

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.

Fischer JS, McLaughlin T, Loza L, Beauchamp R, Schwartz S, Kipnes M.

Curr Med Res Opin. 2004 Nov;20(11):1703-10.PMID: 15537471 [PubMed - indexed for MEDLINE]Related articles

Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine.

Gerich J, Becker RH, Zhu R, Bolli GB.

Diabetes Technol Ther. 2006 Apr;8(2):237-43.PMID: 16734552 [PubMed - indexed for MEDLINE]Related articles

Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.

Pediatr Diabetes. 2007 Jun;8(3):157-62.PMID: 17550426 [PubMed - indexed for MEDLINE]Related articles

Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.

Mullins P, Sharplin P, Yki-Jarvinen H, Riddle MC, Haring HU.

Clin Ther. 2007 Aug;29(8):1607-19.PMID: 17919543 [PubMed - indexed for MEDLINE]Related articles

Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

Bode BW, Steed RD, Schleusener DS, Strange P.

Endocr Pract. 2005 May-Jun;11(3):157-64.PMID: 16239201 [PubMed - indexed for MEDLINE]Related articles

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.

Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, Shutler SD, Stephens JW, Home PD.

Diabet Med. 2006 Mar;23(3):285-92.PMID: 16492212 [PubMed - indexed for MEDLINE]Related articles

Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.

Ashwell SG, Gebbie J, Home PD.

Diabet Med. 2006 Aug;23(8):879-86.PMID: 16911626 [PubMed - indexed for MEDLINE]Related articles

Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.

Heller S, Koenen C, Bode B.

Clin Ther. 2009 Oct;31(10):2086-97.PMID: 19922879 [PubMed - in process]Related articles

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

Malone JK, Kerr LF, Campaigne BN, Sachson RA, Holcombe JH; Lispro Mixture-Glargine Study Group.

Clin Ther. 2004 Dec;26(12):2034-44. Erratum in: Clin Ther. 2005 Jul;27(7):1112. PMID: 15823767 [PubMed - indexed for MEDLINE]Related articles

Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin.

Riccio A, Avogaro A, Valerio A, Zappella A, Tiengo A, Del Prato S.

Diabetes Care. 1994 Jun;17(6):535-40.PMID: 8082521 [PubMed - indexed for MEDLINE]Related articles